Leaving BNY Website

 

You are leaving the BNY Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2024 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
 

To learn more about DRs, please contact DRBrokerSolutions@bnymellon.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE (0.32%), DAX (0.17%), CAC40 (0.21%)

Feb 07 ,2025

  • Synopsis

    • European indices are set to open mostly lower as Asian equities trade mixed Friday. Japan's Nikkei and Topix giving up some of yesterday's gains but should end with a weekly gain. Greater China boards higher but well off their peaks now. Australia and South Korea a few points lower, Taiwan and most of Southeast Asia higher.

    • US futures a little lower, Europe could also see some weakness early on.

    • Friday sees, in central banks, ECB's de Guindos speech at 9:45CET in conf "VI Encuentro Económico-Asegurador" organised by Mutualidad de Abogados de España. Czech central bank presents new economic forecasts at 11:00CET. Embracer Group (EMBRAC.B.SS) spin-off Asmodee (ASMDEE.SS) begins trading on Nasdaq Stockholm

    • Economic due today include: Germany Dec trade balance, industrial production, France Dec trade balance, Spain Dec industrial production, Switzerland Jan consumer confidence, Norway Dec manufacturing production, Denmark Dec manufacturing production, UK Jan house price index - Halifax, Austria Jan PPI

    • Yesterday after the close L'Oreal (OR.FP) reported FY EPS €12.66 vs FactSet €12.18

    • Earnings reported so far: Yit (YIT.FH) reports Q4 EPS (€0.18) vs FactSet €0.02. Talanx (TLX.GR) reports prelim FY net income €1.98B vs FactSet €1.95B; confirms FY25 guidance. Kongsberg Gruppen (KOG.NO) reports Q4 EPS NOK8.27 vs FactSet NOK8.59 [6 est, NOK7.53-9.17]; proposes a five-for-one stock split. Clas Ohlson (CLAS.BSS reports Jan sales +14% to SEK901M; organic sales +14% y/y. Banco de Sabadell (SAB.SM) reports Q4 net income €532M vs StreetAccount €439.9M. Vontobel Holding (VONN.SW) reports FY net income CHF266.1M vs FactSet CHF270.5M. Aperam (APAM.NA) reports FY net income €231M vs FactSet €251.8M [6 est, €244.0-262M]; guides Q1 EBITDA at a lower level versus Q4.

    • Trading Update due at 7am London Time: Buzzi (BZU.IM), Clas Ohlson (CLAS.B.SS), HEXAOM (ALHEX.FP)

    • Traffic: VINCI (DG.FP)

  • Politics/Macro/World News

    • ECB Could Face Biggest Personnel Shakeup Since 2019 This Year (BBG )

    • German 'debt brake' reform may rattle global bond markets (FT )

  • Top company news

    • Earnings/updates

      • OR.FP (L'Oreal) -- reports FY EPS €12.66 vs FactSet €12.18 [24 est, €11.36-12.65]

      • DG.FP (VINCI SA) -- reports FY Attributable net income €5.15B vs consensus €4.74B

      • SCHA.NO (Schibsted) -- reports Q4 EPS (NOK1.37) vs year-ago NOK0.29

      • P911.GR (Porsche) -- guides FY24 automotive net cash flow margin 10%+ vs prior guidance 7-8.5%

      • PAH3.GR (Porsche Automobil Holding SE) -- Porsche SE provides update on impairment charges related to carry amounts in Volkswagen AG and Porsche AG

      • APAM.NA (Aperam) -- reports FY net income €231M vs FactSet €251.8M [6 est, €244.0-262M]; guides Q1 EBITDA at a lower level versus Q4

      • BIOA.B.SS (BioArctic) -- partner Eisai reports Q4/CY24 Leqembi sales ¥13.3B

      • BPE.IM (BPER Banca) -- reports Q4 adjusted net income €296.3M vs FactSet €258.3M (post EU close 6-Feb)

      • EMSN.SW (EMS-Chemie Holding) -- reports FY net income CHF466M vs FactSet CHF454.0M [5 est, CHF441.3-463M]

      • ELI.BB (Elia Group SA/NV) -- Elia group provides update on the Princess Elisabeth Island project

      • XFAB.FP (X-FAB Silicon Foundries) -- reports Q4 net income ($7.3M) vs FactSet $12M [1 est]; provides FY25 guidance

      • NSKOG.NO (Norske Skog) -- reports Q4 EPS (NOK6.54) from cont. ops and unclear if comparable to FactSet (NOK0.91) [2 est, (NOK1.00)-(0.83)]

      • GBT.FP (Guerbet) -- reports Q4 revenue €220.6M vs FactSet €224.5M [1 est]

      • ODF.NO (Odfjell) -- reports Q4 EPS $64.00 vs FactSet $0.72 [5 est, $0.59-0.84]

      • LNA.FP (LNA Santé) -- reports FY revenue €793.9M vs FactSet €798.2M [4 est, €791.5-804.6M]

      • Also reporting today

        • BPER Banca (BPE.IM)

    • M&A

      • BPE.IM (BPER Banca) -- shareholders to vote on 18-Apr on issuance of up to 657.4M shares in connection with offer for Banca Popolare di Sondrio (post EU close 6-Feb)

      • BPSO.IM (Banca Popolare di Sondrio) -- BPER Banca announces all share offer for Banca Popolare di Sondrio with implied value of €9.527/share (post EU close 6-Feb)

      • EQNR.NO (Equinor) -- PRIO SA in talks to buy Equinor's 60% in Peregrino oil field - Folha de S.Paulo

      • EQNR.NO (Equinor) -- PRIO denies report of talks regarding Equinor's stake in Peregrino oil field

      • RI.FP (Pernod Ricard) -- Inbrew Beverages and TPG may team up to acquire Imperial Blue - Economic Times

      • TPEIR.GA (Piraeus Financial Holdings) -- If negotiations succeed, Piraeus Financial to end up with 80% of Ethniki Insurance - Euro2day

      • LTG.LN (Learning Technologies Group) -- shareholders approve acquisition by General Atlantic (Leopard UK Bidco Ltd)

    • Healthcare

      • SAN.FP (Sanofi) -- to commence €2B second tranche of already communicated €5B share buyback

      • GNFT.FP (GENFIT) -- outlines anticipated new clinical trial initiations, development milestones, and data readouts in 2025

      • MEDCL.FP (MedinCell) -- announces the EIB has removed two financial covenants from loan agreement, originally set to take effect on 1-Apr-25

    • Other

      • ABBN.SW (ABB Limited) -- ABB launches new share buyback program of up to $1.5B

      • AAL.LN (Anglo American) -- Botswana indicates interest in raising stake in De Beers, increasing chances for IPO - FT

      • KPN.NA (Royal KPN) -- The Netherlands Authority for Consumers and Markets approves creation of KPN and ABP's new tower company (TowerCo)

      • AVOL.SW (Avolta) -- Avolta's Hudson expands footprint at Omaha's Eppley airfield

      • APAM.NA (Aperam) -- proposes to maintain its base dividend at €2.00/share

      • Gogo|Satcom Direct finalizes multifaceted Memorandum of Understanding (MoU) with Airbus

      • Pegasystems selected to deliver digital platform for UK Armed Forces Recruitment Service contract with Serco

  • Key rating changes

    • Upgrades

      • (WIZZ.LN) Wizz Air Holdings upgraded to buy from hold at HSBC

      • JTC.LN (JTC) -- to buy from hold at Shore Capital Stockbrokers (earlier, timing uncertain)

      • MTRS.SS (Munters Group) -- to buy from hold at Berenberg

      • UNI.SM (Unicaja Banco) -- to buy from neutral at JB Capital Markets (earlier, timing uncertain)

      • WALL.B.SS (Wallenstam) -- to buy from hold at Danske Bank

      • WALL.B.SS (Wallenstam) -- Wallenstam long-term recommendation upgraded to outperform from market perform at Handelsbanken

    • Downgrades

      • MAERSK.B.DC (Maersk) downgraded to sell from hold at DnB Markets

      • MAERSK.B.DC (Maersk) downgraded to hold from buy at SEB

      • LIGHT.NA (Signify) -- to reduce from hold at Kepler Cheuvreux

      • VOLCAR.B.SS (Volvo Car) -- Volvo Car short-term recommendation downgraded to hold from buy at Handelsbanken

      • MYCR.SS (Mycronic) -- to hold from buy at Carnegie Securities

      • PDX.SS (Paradox Interactive) -- to hold from buy at Kepler Cheuvreux

      • PEAB.B.SS (Peab) -- Peab short-term recommendation downgraded to sell from hold at Handelsbanken

  • Data

    • Nikkei (0.57%) to 38841.99

    • Hang Seng +0.40% to 20974.66

    • Shanghai Composite +0.38% to 3283.17

    • S&P futures (10.3) vs prior close of 6106.0

    • €-$ (0.0008) or (0.08%) to 1.0378

    • $-¥ +0.26 or +0.17% to 151.72

    • €-¥ +0.17 or +0.11% to 157.44

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE